B cells and tertiary lymphatic structure found in the tumors of responders in cohort 1
tumor
TUMOR
To gain insight into the mechanisms of therapeutic responses as well as biomarkers of response and resistance, longitudinal tumor samples, including baseline (before combination therapy) and relapse, were taken in the context of therapy, and molecular and immune profiling was performed (Supplementary Fig. 